February 28/Teterboro, N.J./Press Release -- Symrise AG recently finalized two acquisitions and a strategic partnership. Symrise purchased the Brazilian activities of fragrance manufacturer Belmay and will transfer these to its own site. Symrise is also strengthening its dynamically growing natural ingredients business with its acquisition of U.S. manufacturer Trilogy Fragrances. In addition, the company agreed to a strategic partnership with the Swedish biotech firm Indevex regarding the similarly expanding segment of Consumer Health.
“We continue to follow our strategy of extending Symrise’s position in the rapidly expanding emerging markets and sharpening our unique profile with our expansion into innovative market segments. We are especially pleased that, at the start of the new fiscal year, we can announce three measures that put these goals into practice,” said Dr. Heinz-Jürgen Bertram, CEO of Symrise AG. “For consumers in developed nations, having a healthy lifestyle is playing an increasingly important role. Through our strategic partnership with Indevex Biotech, we are selectively expanding our expertise in functional foods and creating an optimal foundation for further product innovations. The purchase of Trilogy Fragrances expands our portfolio of natural perfume oils, particularly in North America.”